David Lawrence, Chief Financial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 10,905 shares at $26.39 ($289K) on 2010-12-01, disclosed to the SEC on 2010-12-03.
Scheduled sale ($289k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.39 | 7,405 | $195K | 67.5% |
| 2 | $26.85 | 3,500 | $94K | 32.5% |
| Total | $26.54 avg | 10,905 | $289K | 100% |
| Filing → |
| ACOR | SELL | 2018-12-06 | $102K | — | Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-06-11 | $1.3M | — | Filing → |